by Fatemeh Rahmatabadi Acute myeloid leukemia (AML) is an aggressive blood cancer marked by the rapid expansion of immature myeloblasts. Despite progress in targeted therapies, resistance remains a major obstacle, especially in patients with mutations that impact the MAPK and…
by Fatemeh Rahmatabadi Acute myeloid leukemia (AML) is the most common myeloid cancer in adults, arising from hematopoietic stem cells and marked by a rapid proliferation of immature myeloblasts. Its genetic and clinical diversity complicates treatment. Key mutated genes include…